Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-20

Clinical Trial Update: Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT [NA]

View source ↗

Summary

A completed clinical trial evaluated 0.05% cyclosporine eye drops for tear film stability in dry eye patients. It also assessed improvement in asthenopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine 0.05% ophthalmic solution (Cyclosporine A)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Dry Eye Disease (DED), Asthenopia | NA | Status: COMPLETED